News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–5
Matches
5
Sources here
1
Companies here
1
Search results Stored financial headlines

Active search

5 matching headlines

Ticker or company: SOBIMain company stories
Clear
Latest

finance.yahoo.com Deals and strategy

Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Swedish Orphan Biovitrum Stock Is Back In Focus Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after a new partnership with Innate Pharma to run the TELLOMAK-3 Phase 3 trial for lacutamab in cutaneous T cell lymphoma. …

Swedish Orphan Biovitrum (OM:SOBI) Stock Looks Strong On Returns But Fully Priced On Earnings

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Swedish Orphan Biovitrum has delivered a strong share price run over the past five years, yet its current valuation checks lean expensive rather …

SOBI main company
Sharemaestro market context Trend signal active 52 weeks +51.5% SOBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

BioNTech SE Mainz, Germany, August 3, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") announced today that its Supervisory Board has appointed Guido Oelkers, Ph.D., to the Management Board as Chief Executive Officer ("CEO"), who will take office by February …

SOBI main company
Sharemaestro market context Trend signal active 52 weeks +51.5% SOBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Guido Oelkers to step down as CEO of Sobi in the beginning of 2027

STOCKHOLM, Aug. 3, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announces that Guido Oelkers has informed the Board of Directors that he has decided to step down as Chief Executive Officer of Sobi to take up another position outside Sobi. Guido …

SOBI main company
Sharemaestro market context Trend signal active 52 weeks +51.5% SOBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Swedish Orphan Biovitrum AB (BIOVF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...

This article first appeared on GuruFocus. Revenue Growth: 29% at constant exchange rates. Adjusted EBITDA Margin: 35% for Q2. Total Net Sales: Just under SEK7.8 billion for the quarter. Geographic Revenue Growth: North America 33%, International markets 45%, Europe 23%. Product Performance: Strong contributions …

SOBI main company
Sharemaestro market context Trend signal active 52 weeks +51.5% SOBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context